Renal Cancer
📧 Sign up to get email alerts when something new happens for Renal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
Enrollment by invitation is underway for a head-to-head evaluation of the COSMO AI system vs. pathologist review. The study includes brain c…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
This ClinicalTrials.gov study is evaluating intra-procedural spectral CT to guide embolization and ablation in interventional oncology for l…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) [NA]
This entry provides an update on the ongoing clinical trial NCT05820087 evaluating the Edison system from HistoSonics for treating primary s…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: A Study of HB0025 Injection in Patients With Advanced Renal Cancer [Phase 2]
Phase 2 clinical trial update for HB0025 injection in patients with advanced renal cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Off Clamp Randomization [NA]
A completed clinical trial investigating off-clamp techniques in renal cancer with conditions including renal cancer and renal ischemia; res…
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating nivolumab plus stereotactic body radiotherapy in II-III line metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Study of Nivolumab for Advanced Cancers in India [Phase 4]
Phase 4 trial update for nivolumab in advanced cancers conducted in India, with completed status and results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex [NA]
A completed clinical trial evaluating the effect of neuromuscular block and arterial PCO2 on the Surgical Rating Scale after reversal with s…
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium [Phase 3]
Phase 3 trial update exploring minocycline to attenuate postoperative cognitive dysfunction and delirium.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive [Phase 1, Phase 2]
Clinical trial update for a T cell receptor therapy targeting MAGE-A3 in HLA-A*01 positive patients with metastatic cancer; the study is ter…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer [Phase 2]
Phase 2 clinical trial of everolimus for Birt-Hogg-Dube syndrome-associated kidney cancer or sporadic chromophobe renal cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 [Phase 1]
Phase 1 trial evaluating a radiolabeled antibody with Yttrium-90 for advanced renal cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes [Phase 3]
Phase 3 trial evaluating mannitol use during partial nephrectomy before renal ischemia and its effect on renal function outcomes has complet…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Pillars4Life Trial [NA]
Duke University's Pillars4Life trial has completed, studying multiple cancer indications including breast, lung, esophageal, colon, pancreat…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating CAR T cell therapy targeting VEGFR2 in patients with metastatic cancer, terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors [Phase 1]
Phase 1 trial evaluating the PET radiotracer IAZGP (124I-iodo-azomycin galacto-pyranoside) for imaging hypoxic tumors; the study is complete…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Phase II Study of Vandetanib in Individuals With Kidney Cancer [Phase 2]
Phase II study of vandetanib in renal cancer and Von Hippel-Lindau syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes [Phase 1, Phase 2]
Phase 1/Phase 2 trial of anti-MAGE-A3/12 TCR-gene engineered lymphocytes in metastatic cancers was terminated. Results were posted in 2013.